Ataxia, Cerebellar, Cayman Type (ATCAY) (C-Term) Peptide
ATCAY
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all ATCAY products
- ATCAY (Ataxia, Cerebellar, Cayman Type (ATCAY))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- LQYEEERLKA RRESARPQPE FVLPRSEEKP EVAPVENRSA LVSEDQETSM
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-ATCAY Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ATCAY (Ataxia, Cerebellar, Cayman Type (ATCAY))
- Synonyms
- BNIP-H Peptide, CLAC Peptide, 3322401A10Rik Peptide, BB077577 Peptide, hes Peptide, ji Peptide, ATCAY, caytaxin Peptide, ataxia, cerebellar, Cayman type Peptide, ATCAY Peptide, Atcay Peptide
- Background
-
This gene encodes a neuron-restricted protein that contains a CRAL-TRIO motif common to proteins that bind small lipophilic molecules. Mutations in this gene are associated with cerebellar ataxia, Cayman type.
Alias Symbols: BNIP-H, CLAC, KIAA1872
Protein Size: 371 - Molecular Weight
- 42 kDa
- Gene ID
- 85300
- NCBI Accession
- NM_033064, NP_149053
- UniProt
- Q86WG3
-
You are here:
